HanAll Biopharma Co., Ltd. ratings

HanAll Biopharma Co., Ltd. ratings in South Korea

HanAll Biopharma Co., Ltd. ratings are monitored online at allstockstoday.com All ratings of HanAll Biopharma Co., Ltd. are taken from open, trusted sources. One rating is different from another. Carefully read the rating description in order to accurately understand its meaning. See and analyze all ratings of HanAll Biopharma Co., Ltd. in real time. It's free.

HanAll Biopharma Co., Ltd. ratings on KSC

HanAll Biopharma Co., Ltd. in the world ranking is a rating by financial indicators among companies around the world. HanAll Biopharma Co., Ltd. ratings are one of the most important indicators of a large company. The ratings of HanAll Biopharma Co., Ltd. in South Korea are a national rating, a rating among financial indicators within the country. The company rating among one country is no less important than the world rating.

HanAll Biopharma Co., Ltd. is #141 in rating Capitalization in South Korea. HanAll Biopharma Co., Ltd. is #127 in rating Capitalization on KSC.

Stock exchange ratings on are compiled by the exchange itself online.The rating “Company capitalization” is a rating by capitalization. Capitalization is the total value of a company or the sum of the price of shares. Companies with higher shares have higher ratings and are more expensive. It is the most expensive companies that make up the top of the list of rating companies by capitalization.

HanAll Biopharma Co., Ltd. earnings per share rating is determined in each financial period. “Earnings per share” is the name of the stock market parameter corresponding to the amount of income in terms of the number of shares of the company for a certain accounting interval. Earnings per share ratings are generally determined by exchanges after the company’s stock reporting of earnings.

Rating HanAll Biopharma Co., Ltd. net income - a rating compiled by the total amount of the company's income for the reporting financial period. Net income is calculated as the total revenue of the company, not taking into account the quantity and value of its shares. Those companies whose profits are the most by absolute value and are at the top of the Net Income rating list.